For example, research shows people taking Rybelsus for diabetes may lose 7.5 pounds after a year and a half of treatment
Beyond shedding pounds, these medications positively impact numerous weight-related conditions: Cardiovascular disease risk reduction of approximately 20% (MACE) with GLP1s Improvements in sleep apnea (reduction of 6 fewer events per hour) Better management of non-alcoholic fatty liver disease Significant improvements in blood pressure, cholesterol, and blood sugar Reduced risk for cardiovascular and all-cause mortality Delayed progression to diabetes The weight loss threshold for meaningful health improvements typically starts at 5-10% of body weight
If you or someone you love uses these medications, be watchful, protective, and supportive in making good nutrient choices, lifestyle changes, and purposeful health-oriented goals
If any severe adverse reactions occur, discontinue use and consult a healthcare professional
Good to excellent test-retest reliability was found for the PROMIS SD SF 8b T-score between Weeks 6 and 7, and Weeks 8 and 9 (intra-class correlation coefficients (ICCs) 0.910-0.927)
For aligner labs and orthodontic practices in Mexico producing high case volumes, the faster cycle time translates to meaningful throughput gains